LIONVILLE, Pa., Sept. 9 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company will participate in two upcoming investor conferences.

Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, and William Federici, Chief Financial Officer, will attend CL King's 8th Annual Best Ideas Conference in New York, NY. Management will present an overview of West's business and outlook on Wednesday, September 15, 2010 at 11:45 AM ET.

Dr. Morel and Mr. Federici will also attend the UBS 2010 Global Life Sciences Conference in New York, NY. Management will present an overview of West's business and outlook on Wednesday, September 22, 2010 at 11:30 AM ET.

A copy of the corporate presentation documents as well as a live audio webcast of the presentations will be posted on the investor link of the Company's website at www.westpharma.com.

About West

West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

                              Investors and
    Contacts:                 Financial Media:
    ---------                 ----------------
    West Pharmaceutical
     Services, Inc.          Westwicke Partners
                              John Woolford/
    Michael A. Anderson       Stefan Loren
    Vice President and
     Treasurer                (443) 213-0506/0507
    (610) 594-3345

SOURCE West Pharmaceutical Services, Inc.